Ligand functionalized polymers

US10526366B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10526366-B2
Application numberUS-201815987441-A
CountryUS
Kind codeB2
Filing dateMay 23, 2018
Priority dateMar 3, 2010
Publication dateJan 7, 2020
Grant dateJan 7, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.

First claim

Opening claim text (preview).

The invention claimed is: 1. A complex comprising: a) a water-soluble or water-dispersible aminopolymer functionalized with pendent or catenary guanidinyl groups; and b) a neutral or negatively charged target biological species in a biological fluid, wherein 2 to 10 mole percent of the available amino groups of the aminopolymer functionalized with guanidinyl groups are alkylated and/or acylated. 2. The complex of claim 1 wherein the complex is a precipitated solid. 3. The complex of claim 1 wherein the aminopolymer selected from the group consisting of polyethylenimine, polylysine, polyaminoamides, polyallylamine, polyvinylamine, polydimethylamine-epichlorohydrin-ethylenediamine, polyaminosiloxanes and dendrimers formed form polyamidoamine (PAMAM) and polypropylenimine. 4. The complex of claim 1 wherein the aminopolymer is polyethylenimine or polyallylamine. 5. The complex of claim 1 wherein the target biological species is cells or cell debris. 6. The complex of claim 1 wherein the target biological species protein or enzyme. 7. The complex of claim 1 wherein the target biological species comprises antibodies. 8. The complex of claim 2 wherein the salt concentration of the biological fluid is between 0 and 300 millimolar. 9. The complex of claim 2 wherein the salt concentration of fluid is between 150 to 300 millimolar. 10. The complex of claim 2 wherein the salt concentration of the fluid is at least 150 mM. 11. The complex of claim 1 wherein the amount of aminopolymer functionalized with guanidinyl groups relative to the amount of target biological species is 0.01% to 100% by weight. 12. The complex of claim 11 wherein the amount of aminopolymer functionalized with guanidinyl groups relative to the amount of target biological species is 0.1%-10% by weight. 13. The complex of claim 1 wherein the aminopolymer functionalized with guanidinyl groups is present in amounts of 0.01 to 5000 micrograms/mL of fluid. 14. The complex according to claim 1 , wherein the complex precipitates from the fluid. 15. The complex of claim 1 wherein at least some of the aminopolymer functionalized with guanidinyl groups is of the formula: wherein R 2 is a H, C 1 -C 12 alkyl, C 5 -C 12 (hetero)aryl, or a residue of the polymer chain; each R 3 is independently H, C 1 -C 12 alkyl, or C 5 -C 12 (hetero)aryl, each R 4 is H, C 1 -C 12 alkyl or alkylene, C 5 -C 12 (hetero)aryl or (hetero)arylene, cyano, or —C(═NH)—N(R 2 )-Polymer, and n is 1 or 2.

Assignees

Inventors

Classifications

  • Synthetic resin · CPC title

  • Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title

  • from polyamines and epihalohydrins · CPC title

  • Polyalkylene(poly)amines · CPC title

  • Polyamidoamines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10526366B2 cover?
Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.
Who is the assignee on this patent?
3M Innovative Properties Co
What technology area does this patent fall under?
Primary CPC classification C08G69/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).